US 9782345
Ocular composition and method
granted A61KA61K31/407A61K31/4709
Quick answer
US patent 9782345 (Ocular composition and method) held by Jade Therapeutics, Inc. expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jade Therapeutics, Inc.
- Grant date
- Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/407, A61K31/4709, A61K31/522, A61K31/5575